<DOC>
	<DOCNO>NCT02373332</DOCNO>
	<brief_summary>This study investigate potential protective effect alter fatty acid platelet method prevention platelet activation thrombosis type 2 diabetes mellitus . Fatty acid ( omega-3 omega-6 ) oxidize lipid evaluate protection agonist-mediated platelet activation platelet type 2 diabetic healthy control .</brief_summary>
	<brief_title>Fatty Acid Regulation Platelet Function Diabetes</brief_title>
	<detailed_description>12-lipoxygenase essential fatty acid omega-3 omega-6 show play important role regulate platelet activation , underlie mechanism fully elucidate well true protection thrombosis . 12-lipoxygenase inhibition prevents platelet activation part inhibit 12-lipoxygenase oxidation free fatty acid platelet . These oxidized fatty acid know play pro- anti-thrombotic effect platelet depend fatty acid . oxidation arachidonic acid 12-lipoxygenase result pro-thrombotic bioactive lipid whereas oxidation omega-6 fatty acid DGLA find plant oil result formation potent anti-thrombotic bioactive lipid . Determining extent protection bioactive lipid produce 12-lipoxygenase allow well understanding fatty acid supplementation may best protect thrombosis . Essential fatty acid omega-3 ( DHA/EPA ) omega-6 ( DGLA ) appear protective . However underlying mechanism potential protection well understood . Identifying mechanism supplement protect platelet activation may identify new approach prevent thrombotic event high risk population .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<criteria>Healthy subject T2DM patient African American Caucasian T2DM patient control medication ( take metformin ) Dietary supplement within 2 week enrollment Fish plant oil supplement 2 month prior enrollment NSAIDS aspirin 1 week prior enrollment Smoking Cardiovascular event within 6 month prior enrollment Other antiplatelet treatment include phosphodiesterase ( PDE ) P2Y12R inhibitor Estimated Glomerular Filtration Rate ( eGFR ) 30 ( severe renal insufficiency ) eGFR 90</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>platelet</keyword>
	<keyword>12-lipoxygenase</keyword>
	<keyword>fatty acid</keyword>
	<keyword>DGLA</keyword>
	<keyword>DHA</keyword>
	<keyword>EPA</keyword>
	<keyword>12-LOX</keyword>
</DOC>